Recent News

• 02.11.2026 - Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series
• 11.04.2025 - Cryoport Reports Third Quarter 2025 Financial Results
• 10.30.2025 - Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
• 10.21.2025 - Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025
• 10.07.2025 - MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
• 10.01.2025 - Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France

Recent Filings

• 02.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 12.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.10.2025 - 144 Report of proposed sale of securities
• 11.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.04.2025 - EX-99.1 EX-99.1
• 11.04.2025 - 8-K Current report
• 09.26.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.11.2025 - 144 Report of proposed sale of securities